Cellectar Biosciences (CLRB) Stock: Gaining On Fast Track Designation
Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has been granted Fast Track Designation by the FDA, exciting investors and sending the stock for the top. Today, we’ll talk about: The Fast Track Designation; what we’re seeing … Read more
